VEGFA and COVID-19: In recent years, DNA and RNA GQs have gained much interest as targets for antiviral [155, 156] and anticancer therapy [157, 158]; studies include, among others, inhibition of the translation of COVID-19 nucleocapsid phosphoprotein [159], inhibition of the translation of vascular endothelial growth factor [160], and suppression of c-myc transcription [161].